BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11450022)

  • 1. Effects of brain oedema in the measurement of ischaemic brain damage in focal cerebral infarction.
    Park CK; Kang SG
    Acta Neurochir Suppl; 2000; 76():269-71. PubMed ID: 11450022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
    Park CK; McCulloch J; Kang JK; Choi CR
    Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental stroke: ischaemic lesion volume and oedema formation differ among rat strains (a comparison between Wistar and Sprague-Dawley rats using MRI).
    Walberer M; Stolz E; Müller C; Friedrich C; Rottger C; Blaes F; Kaps M; Fisher M; Bachmann G; Gerriets T
    Lab Anim; 2006 Jan; 40(1):1-8. PubMed ID: 16460584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
    McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
    Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation.
    Valtysson J; Hillered L; Andiné P; Hagberg H; Persson L
    Acta Neurochir (Wien); 1994; 129(1-2):58-63. PubMed ID: 7998497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pattern of time-dependent reduction of histologically determined infarct volume after focal ischaemia in mice.
    Henrich-Noack P; Baldauf K; Reiser G; Reymann KG
    Neurosci Lett; 2008 Feb; 432(2):141-5. PubMed ID: 18222610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of different fixation procedures on the quantification of infarction and oedema in a rat model of stroke.
    Overgaard K; Meden P
    Neuropathol Appl Neurobiol; 2000 Jun; 26(3):243-50. PubMed ID: 10886682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
    Park CK; McCulloch J; Jung DS; Kang JK; Choi CR
    Acta Neurochir Suppl (Wien); 1994; 60():279-81. PubMed ID: 7976566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of proteolytic enzymes in focal ischaemic brain damage.
    Davis M; Mantle D; Mendelow AD
    Acta Neurochir Suppl; 2000; 76():261-4. PubMed ID: 11450020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of age on cerebral oedema, cerebral infarction and neuroprotective potential in experimental occlusive stroke.
    Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
    Acta Neurochir Suppl (Wien); 1994; 60():282-4. PubMed ID: 7976568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
    Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
    Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model.
    Shuaib A; Xu Wang C; Yang T; Noor R
    Stroke; 2002 Dec; 33(12):3033-7. PubMed ID: 12468809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.
    Lin TN; He YY; Wu G; Khan M; Hsu CY
    Stroke; 1993 Jan; 24(1):117-21. PubMed ID: 8418534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fullerenol nanoparticles decrease ischaemia-induced brain injury and oedema through inhibition of oxidative damage and aquaporin-1 expression in ischaemic stroke.
    Darabi S; Mohammadi MT
    Brain Inj; 2017; 31(8):1142-1150. PubMed ID: 28506130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting for Brain Swelling's Effects on Infarct Volume Calculation After Middle Cerebral Artery Occlusion in Rats.
    McBride DW; Klebe D; Tang J; Zhang JH
    Transl Stroke Res; 2015 Aug; 6(4):323-38. PubMed ID: 25933988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental stroke and neuroprotection in the aging rat brain.
    Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
    Stroke; 1995 Jun; 26(6):1072-8. PubMed ID: 7762026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E; Planas AM; Amaro S; Chamorro A
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology.
    Gill R; Sibson NR; Hatfield RH; Burdett NG; Carpenter TA; Hall LD; Pickard JD
    J Cereb Blood Flow Metab; 1995 Jan; 15(1):1-11. PubMed ID: 7798326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
    Elger B; Seega J; Raschack M
    Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.